Advertisement

Biological Trace Element Research

, Volume 5, Issue 4–5, pp 307–315 | Cite as

Interaction between dietary selenium and 2-acetylaminofluorene in the rat

  • Arthur M. Cohen
Article

Abstract

The effect of dietary selenium on the metabolism of 2-acetylaminofluorene (AAF) and on its interaction with hepatic DNA was studied in male, Charles River rats. All studies were commenced at least 3 weeks after placing weanling rats on a tomla yeastbased Se-deficient diet or the same diet supplemented with 0.5 ppm Se as Na2SeO3.

Analysis of radioactive metabolites generated during in vitro incubation of [9-14C]-AAF with hepatic microsomes showed that Se-supplemented rats produced greater amounts of noncarcinogenic, phenolic metabolites than did Se-deficient animals. No significant difference was noted between the two dietary groups with respect to the production of the proximate carcinogenic metabolite,N-hydroxy-AAF.

Analysis of urinary metabolites excreted during a 24-h period following a single ip injection of [9-14C]-AAF showed that Se-deficient animals produced 2–3 times as much N-hydroxy-AAF as did the supplemented rats. The increased excretion of the proximate carcinogenic metabolite by Se-deficient rats occurred both as the free and glucuronic acid conjugated forms. In contrast, Se-deficient rats excreted lower amounts of noncarcinogenic AAF metabolites. Taken together, these results suggest that dietary Se alters AAF biotransformation so as to decrease metabolic activation while enhancing detoxification pathways.

The effect of dietary Se on AAF-DNA interactions was assessed in two ways. First, it was found that Se had no effect on the total amount of AAF residues covalently bound to hepatic DNA in vivo. This lack of effect was observed both at early (1-24 h) and late (4-7 d) intervals after administering a single ip injection of [9-14C]-AAF to rats from both dietary groups. In contrast, alkaline sucrose gradient analysis revealed a marked protective.effect of Se against AAF-induced DNA single-strand breaks. Further studies showed that the protective effect of Se was not mediated by a more rapid rate of repair of DNA damage. Accordingly, in addition to its favorable actions on carcinogen metabolism, the ability of Se to protect DNA against reactive metabolites may play a role in its reported anticarcinogenic activity.

Index Entries

Selenium, and 2-acetylaminofluorene metabolism 2-acetylaminofluorene, effect of Se on the metabolism of metabolism, of 2-acetylaminofluorene, effect of Se on DNA damage, and Se rat, effect of Se on 2-acetylaminofluorene metabolism liver, Se effect on the metabolism of 2-acetylaminofluorene in 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    K. Schwarz and C. M. Folz,J. Am. Chem. Soc. 79, 3292 (1957).CrossRefGoogle Scholar
  2. 2.
    J. T. Rotruck, A. L. Pope, H. E. Ganther, A. B. Swanson, D. G. Hafeman, and W. G. Hoekstra,Science 179, 588 (1973).PubMedCrossRefGoogle Scholar
  3. 3.
    G. N. Schrauzer, D. A. White, and C. J. Schneider,Bioinorg. Chem. 7, 23 (1977).PubMedCrossRefGoogle Scholar
  4. 4.
    R.J. Shamberger, S. A. Tytko, and C. E. Willis,Arch., Env. Health 31, 231 (1976).Google Scholar
  5. 5.
    A. Co Griffin,Adv. Canc. Res. 29, 419 (1979).CrossRefGoogle Scholar
  6. 6.
    M. M. Jacobs,Prey. Med. 9, 362 (1980).CrossRefGoogle Scholar
  7. 7.
    G. N. Schrauzer and DI Ishmael,Ann. Clin. Lab. Sci. 4, 441 (1974).PubMedGoogle Scholar
  8. 8.
    G. N. Schrauzer, J. E. McGinness, and K. Kuehn,Carcinogenesis 1, 199 (1980).CrossRefGoogle Scholar
  9. 10.
    J. Speirer and L. W. Wattenberg,J. Natl. Canc. Inst. 55, 469 (1975).Google Scholar
  10. 11.
    T. J. Slaga and M. W. Bracken,Canc. Res. 37, 1631 (1977)Google Scholar
  11. 12.
    L. W. Wattenberg,Adv. Canc. Res. 26, 197 (1978).CrossRefGoogle Scholar
  12. 13.
    J. R. Debaun, E. C. Miller, and J. A. Miller,Canc. Res. 30, 577 (1970).Google Scholar
  13. 14.
    J. R. Debaun, J. Y. R. Smith, E. Co Miller, and J. A. Miller,Science 167, 184 (1970).PubMedCrossRefGoogle Scholar
  14. 15.
    H. Bartsch, C. Dworkin, E. C. Miller, and J. A. Miller,Biochim. Biophys. Acta 304, 42 (1973).PubMedGoogle Scholar
  15. 16.
    C. M. King,Canc. Res. 34, 1503 (1974).Google Scholar
  16. 17.
    Ho Bartsch and E. Hecker,Biochim. Biophys. Acta 273, 567 (1971).Google Scholar
  17. 18.
    R. Ao Floyd, L. M. Soong, and P. L. Culver,Canc. Res. 36, 1510 (1976).Google Scholar
  18. 19.
    E. C. Miller,Canco Res. 38, 1479 (1978).Google Scholar
  19. 20.
    G. Brambrilla, M. Cavana, and S. Parodi,Pharmacol. Res. Commun. 10, 693 (1978).CrossRefGoogle Scholar
  20. 21.
    J. Zubroff and D. S. R. Sarma,Anal. Biochem. 70, 387 (1976).PubMedCrossRefGoogle Scholar
  21. 22.
    B. M. Ulland, J-. H. Weisburger, R. S. Yamaoto, and E. K. Weisburger,Food Cosmet. Toxicol. 11, 199 (1973).PubMedCrossRefGoogle Scholar
  22. 23.
    A. M. Benson, R. P. Batzinger, S. L. Ow, E. Bireding, Y. N. Cha, and P. Talalay,Canc. Res. 38, 4486 (1978).Google Scholar
  23. 24.
    A.M. Benson, Y. N. Cha, E. Bueding, H. S. Heine, and P. Talalay,Canc. Res. 39, 2971 (1979).Google Scholar
  24. 25.
    R. A. Lawrence and R. F. Burk,Biochem. Res. Commun. 71, 952 (1976).CrossRefGoogle Scholar
  25. 26.
    W. L. Stone and E. A. Dratz,Biochim. Biophys. Acta 631, 503 (1980).PubMedGoogle Scholar
  26. 27.
    M. M. Jacobs, T. S. Matney, and A. C. Griffin,Canc. Lett. 2, 319 (1977).CrossRefGoogle Scholar
  27. 28.
    M. P. Rosin and H. F. Stich,Int. J. Canc. 23, 722 (1979).CrossRefGoogle Scholar
  28. 29.
    R. H. McKee and A. Mo Tometska,J. Natl. Canc. Inst. 63, 473 (1979).Google Scholar
  29. 30.
    L. M. Calle and P. D. Sullivan,Mutat. Res. 101, 99 (1982).PubMedCrossRefGoogle Scholar
  30. 31.
    L. S. Andrews, J. A. Hinson, and J. R. Gillette,Biochem. Pharmacol. 27, 2399 (1978).PubMedCrossRefGoogle Scholar
  31. 32.
    C.E. Weeks, W. T. Allahen, S. C. Louie, E. J. Lazear, and C. M. King,Canc. Res. 38, 613 (1978).Google Scholar

Copyright information

© Humana Press Inc. 1983

Authors and Affiliations

  • Arthur M. Cohen
    • 1
  1. 1.University of Southern CaliforniaSchool of Pharmacy and Institute for ToxicologyLos Angeles

Personalised recommendations